Reconstitution in Proteoliposomes of the Recombinant Human Riboflavin Transporter 2 (SLC52A2) Overexpressed in E. coli
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reconstitution in Proteoliposomes of the Recombinant Human Riboflavin Transporter 2 (SLC52A2) Overexpressed in E. coli
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 18, Pages 4416
Publisher
MDPI AG
Online
2019-09-09
DOI
10.3390/ijms20184416
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cryo-EM structure of the human neutral amino acid transporter ASCT2
- (2018) Alisa A. Garaeva et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- SWISS-MODEL: homology modelling of protein structures and complexes
- (2018) Andrew Waterhouse et al. NUCLEIC ACIDS RESEARCH
- Genetic, Radiologic, and Clinical Variability in Brown-Vialetto-van Laere Syndrome
- (2018) Ian R. Woodcock et al. Seminars in Pediatric Neurology
- Cryo-EM structure of the human neutral amino acid transporter ASCT2
- (2018) Alisa A. Garaeva et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Characterization of Exosomal SLC22A5 (OCTN2) carnitine transporter
- (2018) Lara Console et al. Scientific Reports
- OCTN: A Small Transporter Subfamily with Great Relevance to Human Pathophysiology, Drug Discovery, and Diagnostics
- (2018) Lorena Pochini et al. SLAS Discovery
- SLC52A2 [p.P141T] and SLC52A3 [p.N21S] causing Brown-Vialetto-Van Laere Syndrome in an Indian patient: First genetically proven case with mutations in two riboflavin transporters
- (2016) Tamilarasan Udhayabanu et al. CLINICA CHIMICA ACTA
- Riboflavin transport and metabolism in humans
- (2016) Maria Barile et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Immuno-detection of OCTN1 (SLC22A4) in HeLa cells and characterization of transport function
- (2015) Lorena Pochini et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1
- (2015) Manuele Rebsamen et al. NATURE
- Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2
- (2013) A. Reghan Foley et al. BRAIN
- Novel riboflavin transporter family RFVT/SLC52: Identification, nomenclature, functional characterization and genetic diseases of RFVT/SLC52
- (2013) Atsushi Yonezawa et al. MOLECULAR ASPECTS OF MEDICINE
- Proteoliposomes as Tool for Assaying Membrane Transporter Functions and Interactions with Xenobiotics
- (2013) Mariafrancesca Scalise et al. Pharmaceutics
- Impaired riboflavin transport due to missense mutations in SLC52A2 causes Brown-Vialetto-Van Laere syndrome
- (2012) Tobias B. Haack et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Riboflavin transporter 3 involvement in infantile Brown-Vialetto-Van Laere disease: two novel mutations
- (2012) Marianna Ciccolella et al. JOURNAL OF MEDICAL GENETICS
- Reconstitution in liposomes of the functionally active human OCTN1 (SLC22A4) transporter overexpressed inEscherichia coli
- (2011) Lorena Pochini et al. BIOCHEMICAL JOURNAL
- The mitochondrial carnitine/acylcarnitine carrier: Function, structure and physiopathology
- (2011) Cesare Indiveri et al. MOLECULAR ASPECTS OF MEDICINE
- Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment
- (2010) Annet M. Bosch et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Identification and Comparative Functional Characterization of a New Human Riboflavin Transporter hRFT3 Expressed in the Brain
- (2010) Yoshiaki Yao et al. JOURNAL OF NUTRITION
- Over-expression in E. coli and purification of the human OCTN1 transport protein
- (2009) Michele Galluccio et al. PROTEIN EXPRESSION AND PURIFICATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More